Jonathan F Smith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jonathan F Smith

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

Biorxiv : the Preprint Server for Biology|November 14, 2023

Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccineMai Komori, Amber L Morey, Andrés A Quiñones-Molina, et al.

Iscience|February 18, 2026

Safety, immunogenicity, and optimal dosing of VLPCOV-02, a SARS-CoV-2 saRNA vaccine with modified 5-methylcytosine baseMasayuki Aboshi, Daisuke Kawakami, Kaoru Kono, et al.

Vaccine|October 17, 2009

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesJay W Hooper, Anthony M Ferro, Joseph W Golden, et al.

The American Journal of Tropical Medicine and Hygiene|October 5, 2002

An outbreak of West Nile virus in a New York City captive wildlife populationGeorge V Ludwig, Paul P Calle, Joseph A Mangiafico, et al.

Iscience|February 14, 2024

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosineMasayuki Aboshi, Kenta Matsuda, Daisuke Kawakami, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2025

Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch deliveryMadison M Driskill, Ian A Coates, Paul J Hurst, et al.

Journal of Virology|April 22, 2024

A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primatesDaniel Thoresen, Kenta Matsuda, Akane Urakami, et al.

Vaccine|October 27, 2007

Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaBolyn Hubby, Todd Talarico, Maureen Maughan, et al.

Nature Communications|May 19, 2023

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.

Cell Reports. Medicine|August 16, 2023

Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.

Pageof 3

Search research articles

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

Biorxiv : the Preprint Server for Biology|November 14, 2023

Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccineMai Komori, Amber L Morey, Andrés A Quiñones-Molina, et al.

Iscience|February 18, 2026

Safety, immunogenicity, and optimal dosing of VLPCOV-02, a SARS-CoV-2 saRNA vaccine with modified 5-methylcytosine baseMasayuki Aboshi, Daisuke Kawakami, Kaoru Kono, et al.

Vaccine|October 17, 2009

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesJay W Hooper, Anthony M Ferro, Joseph W Golden, et al.

The American Journal of Tropical Medicine and Hygiene|October 5, 2002

An outbreak of West Nile virus in a New York City captive wildlife populationGeorge V Ludwig, Paul P Calle, Joseph A Mangiafico, et al.

Iscience|February 14, 2024

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosineMasayuki Aboshi, Kenta Matsuda, Daisuke Kawakami, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2025

Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch deliveryMadison M Driskill, Ian A Coates, Paul J Hurst, et al.

Journal of Virology|April 22, 2024

Vaccine|October 27, 2007

Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaBolyn Hubby, Todd Talarico, Maureen Maughan, et al.

Nature Communications|May 19, 2023

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.

Cell Reports. Medicine|August 16, 2023

Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.

Pageof 3